FDA.reportPublic FDA data

Tirosint

Product NDC
24090-494
11-digit product format
240900494
Labeler code
24090
Product ID
24090-494_a4458922-b538-42d6-b4d3-7942ee950f04
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Levothyroxine Sodium
Dosage form
CAPSULE
Route
ORAL
Labeler
Akrimax Pharmaceuticals, LLC
Application
NDA021924
Marketing category
NDA
Marketing start
2010-04-01
Marketing end
0000-00-00
Substance
LEVOTHYROXINE SODIUM
Active strength
88 ug/1
Pharmacologic classes
l-Thyroxine [EPC],Thyroxine [CS]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
24090-494-072020-09-15C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-494-842020-09-15C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-494-942020-09-15C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-494-992020-09-15C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-494-072020-01-31C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-494-842020-01-31C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-494-942020-01-31C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-494-992020-01-31C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
24090-494-84EA - Each24090-49479f559e6-0d47-4d9a-b71f-efbfc157b3a612012-07-24